💡Next Week: Join us for the IPNA Webinar : International expert consensus statement on the diagnosis and management of Congenital Nephrogenic Diabetes Insipidus (NDI)

🌍 Join our next IPNA webinar — now in your language!

We are using Wordly AI translation on Zoom, offering real-time captions and audio translation in 50+ languages.

Don’t miss this opportunity to connect and learn — wherever you are, whatever language you speak.

IPNA Webinar: Congenital Nephrogenic Diabetes Insipidus

Speakers:  Nine Knoers (Netherlands), Elena Levtchenko (Netherlands)

Moderator: Eugene Chan (Hong Kong)

Congenital nephrogenic diabetes insipidus (NDI), also known as arginine vasopressin resistance, is a rare inherited disorder of water homeostasis caused by reduced responsiveness of the distal nephron to arginine vasopressin. As a result, the kidneys are unable to concentrate urine, leading to polyuria, polydipsia, and an increased risk of hypertonic dehydration. Diagnosis and management are complex and require a coordinated, multidisciplinary approach. Recently, an international panel of experts in paediatric and adult nephrology, urology, clinical genetics, together with patient advocates, developed recommendations for the diagnosis, treatment, and follow-up of both children and adults with NDI. These guidelines also address emergency management, genetic counselling, and family planning. In this webinar, we will review these recommendations and highlight the need for continued research to inform the development of future evidence-based guidelines for this potentially life-threatening condition.

REGISTER HERE.